The ConvertX Biliary Stent System is part of BrightWater Medical’s ConvertX Stent Family, which includes the company’s innovative ConvertX Nephroureteral Stent System cleared by the FDA for treatment of ureteral obstructions. That system enables the IR to eliminate a second invasive interventional procedure in treating patients with severe ureteral blockages.
The ConvertX Stent Family was featured at the Advanced Interventional Management (AIM) Symposium in New York City in November 2018 as the lead presentation during the “New and Innovative Technologies” section. BrightWater received its medical device manufacturing license from the California Department of Public Health and manufactures the ConvertX Stent Family at its facility in Temecula, CA.
Ad Statistics
Times Displayed: 112759
Times Visited: 6727 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About BrightWater™ Medical
BrightWater Medical is a mid-stage medical device company uniquely positioned to significantly impact treatments provided by interventional radiologists. The company was founded by Dr. Bob Smouse, Professor of Radiology & Surgery, University of Illinois College of Medicine. Dr. Smouse is a leading interventional radiologist, clinician, academic and entrepreneur, with more than 20 years of experience in interventional radiology, endovascular surgery and clinical research. The company is developing additional ConvertX-based products for other staged procedure treatments in interventional radiology.
Back to HCB News
